Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization

被引:11
作者
Choi, Seung Joon [1 ]
Kim, Jonghoon [2 ]
Seo, Jongbum [3 ]
Kim, Hyung Sik [1 ]
Lee, Jong-min [4 ]
Park, Hyunjin [2 ]
机构
[1] Gachon Univ, Gil Hosp, Dept Radiol, Inchon, South Korea
[2] Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea
[3] Yonsei Univ, Dept Biomed Engn, Wonju, South Korea
[4] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea
来源
ABDOMINAL IMAGING | 2014年 / 39卷 / 03期
基金
新加坡国家研究基金会;
关键词
Hepatocellular carcinoma; Parametric response mapping; Automatic classifier; Transcatheter arterial chemoembolization; Dynamic CT; Longitudinal exam; TRANSARTERIAL CHEMOEMBOLIZATION; LIPIODOL-CHEMOEMBOLIZATION; EMBOLIZATION; THERAPY; MAP; LIVER; RECURRENCES; COMBINATION; MANAGEMENT; SORAFENIB;
D O I
10.1007/s00261-014-0087-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Accurate assessment of viability of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is important for therapy planning. The purpose of this study is to determine the diagnostic value of a novel image analysis method called parametric response mapping (PRM) in predicting viability of tumor in HCC treated with TACE for dynamic CT images. 35 patients who had 35 iodized-oil defect areas (IODAs) in HCCs treated with TACE were included in our study. These patients were divided into two groups, one group with viable tumors (n = 22) and the other group with non-viable tumors (n = 13) in the IODA. All patients were followed up using triple-phase dynamic CT after the treatment. We compared (a) manual analysis, (b) using PRM results, and (c) using PRM results with automatic classifier to distinguish between two tumor groups based on dynamic CT images from two longitudinal exams. Two radiologists performed the manual analysis. The PRM approach was implemented using prototype software. We adopted an off-the-shelf k nearest neighbor (kNN) classifier and leave-one-out cross-validation for the third approach. The area under the curve (AUC) values were compared for three approaches. Manual analysis yielded AUC of 0.74, using PRM results yielded AUC of 0.84, and using PRM results with an automatic classifier yielded AUC of 0.87. We improved upon the standard manual analysis approach by adopting a novel image analysis method of PRM combined with an automatic classifier.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 50 条
[41]   Impact of Insufficient Response with an Increase in Tumor Number in Predicting Transcatheter Arterial Chemoembolization Refractoriness for Hepatocellular Carcinoma [J].
Furuta, Mitsuhiro ;
Moriguchi, Michihisa ;
Okuda, Keiichiro ;
Kataoka, Seita ;
Mizuno, Naoki ;
Takemura, Masashi ;
Taketani, Hiroyoshi ;
Hara, Tasuku ;
Seko, Yuya ;
Umemura, Atsushi ;
Nishikawa, Taichiro ;
Yamaguchi, Kanji ;
Yasui, Koichiroh ;
Minami, Masahito ;
Itoh, Yoshito .
DIGESTIVE DISEASES, 2018, 36 (05) :385-394
[42]   Nonresectable Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Analysis of the Response and Prognostic Factors after Transcatheter Arterial Chemoembolization [J].
Kim, Jin Hyoung ;
Yoon, Hyun-Ki ;
Ko, Gi-Young ;
Gwon, Dong Il ;
Jang, Cheol Soo ;
Song, Ho-Young ;
Shin, Ji Hoon ;
Sung, Kyu-Bo .
RADIOLOGY, 2010, 255 (01) :270-277
[43]   HIF-1α and VEGF levels for monitoring hepatocellular carcinoma treatment response to transcatheter arterial chemoembolization [J].
Liu, Kang ;
Yang, Lin ;
Zhang, Xiao-Ming ;
Zhou, Yi ;
Zhu, Tao ;
Miao, Nan-Dong ;
Ren, Yong-Jun ;
Xu, Hao ;
Peng, Juan ;
Yang, Ke ;
Yang, Shi ;
Min, Xu-Li .
TRANSLATIONAL CANCER RESEARCH, 2017, 6 (06) :1043-1049
[44]   GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization [J].
Liang, Kung-Hao ;
Lin, Chih-Lang ;
Chen, Sung-Fang ;
Chiu, Chih-Wei ;
Yang, Pei-Ching ;
Chang, Ming-Ling ;
Lin, Chen-Chun ;
Sung, Kai-Feng ;
Yeh, Cassandra ;
Hung, Chien-Fu ;
Chien, Rong-Nan ;
Yeh, Chau-Ting .
PHARMACOGENOMICS, 2016, 17 (04) :353-366
[45]   Therapeutic analysis of 632 cases treated by transcatheter arterial chemoembolization combined with ablation in hepatocellular carcinoma: A retrospective study [J].
Jing, Changyou ;
Li, Jianjun ;
Yuan, Chunwang ;
Hu, Caixia ;
Ma, Liang ;
Zheng, Jiasheng ;
Zhang, Yonghong .
EUROPEAN JOURNAL OF RADIOLOGY, 2024, 178
[46]   Biomarker, efficacy and safety analysis of transcatheter arterial chemoembolization combined with atezolizumab and bevacizumab for unresectable hepatocellular carcinoma [J].
Zhang, Shaobo ;
Zhu, Zebin ;
Liu, Lianxin ;
Nashan, Bjorn ;
Zhang, Shugeng .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (07)
[47]   Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization for hepatocellular carcinoma [J].
Kubota, Kei ;
Yamanishi, Tomoaki ;
Itoh, Satoshi ;
Murata, Yoriko ;
Miyatake, Kana ;
Yasunami, Hiroaki ;
Morio, Kazuo ;
Hamada, Norihiko ;
Nishioka, Akihito ;
Ogawa, Yasuhiro .
ONCOLOGY REPORTS, 2010, 24 (03) :727-732
[48]   Hepatocellular carcinoma treated with transarterial chemoembolization: Dynamic perfusion-CT in the assessment of residual tumor [J].
Ippolito, Davide ;
Bonaffini, Pietro Andrea ;
Ratti, Laura ;
Antolini, Laura ;
Corso, Rocco ;
Fazio, Ferruccio ;
Sironi, Sandro .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (47) :5993-6000
[49]   Hepatocellular carcinoma associated with budd-chiari syndrome: imaging features and transcatheter arterial chemoembolization [J].
Feng-Yong Liu ;
Mao-Qiang Wang ;
Feng Duan ;
Qing-Sheng Fan ;
Peng Song ;
Yan Wang .
BMC Gastroenterology, 13
[50]   Durable complete response is achieved by balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma [J].
Shirono, Tomotake ;
Iwamoto, Hideki ;
Niizeki, Takashi ;
Shimose, Shigeo ;
Kajiwara, Akira ;
Suzuki, Hiroyuki ;
Kamachi, Naoki ;
Noda, Yu ;
Okamura, Shusuke ;
Nakano, Masahito ;
Kuromatsu, Ryoko ;
Murotani, Kenta ;
Koga, Hironori ;
Torimura, Takuji .
HEPATOLOGY COMMUNICATIONS, 2022, 6 (09) :2594-2604